Glycemic Response to Different Food Combinations

February 3, 2023 updated by: Daniela Freitas, Hospital de Santo Espírito

Investigation of the Impact of Food Combination Strategies on Postprandial Blood Glucose Responses

The purpose of this study is to assess the impact of combining starch rich foods with low pH foods on the glycemic response to meals

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Low pH foods can attenuate the glycemic response to starch-rich foods. It has been demonstrated that lemon juice, due to its low pH (pH≈2.3) inhibited key digestive enzymes thereby interrupting gastric digestion of starch in vitro. This effect can significantly reduce the glycemic response in humans. In particular, adding lemon juice to a starch rich meal reduced the mean blood glucose concentration peak by 30%.

Considering the panoply of food options available, it is likely that other combinations have similar effects but no work has been conducted to develop a consolidated knowledge base to exploit this strategy. GlucoMatchMaker will go beyond the state-of-the art by addressing this knowledge gap. The main goal is to develop and test the real-life impact of pH-based food combination strategies on glycemic responses.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Azores
      • Angra Do Heroísmo, Azores, Portugal, 9700-049
        • Hospital de Santo Espírito da Ilha Terceira
      • Angra Do Heroísmo, Azores, Portugal, 9700-702
        • TERInov

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject has given written informed consent
  • Subject is available to participate in the study sessions on the proposed dates.

Exclusion Criteria:

  • Subject has an allergy or intolerance to any food and/or ingredient in the study meals
  • Body mass index ≤ 18.5 kg/m2 or ≥ 30.0 kg/m2.
  • Diagnosed mouth, throat or active gastrointestinal pathology that may affect normal ingestion and digestion of food.
  • History of pancreatic disease
  • Subject is immunocompromised (HIV positive, transplant patient, on antirejection medications, on a steroid for >30 days, or chemotherapy or radiotherapy within the last year).
  • Subject has Type 1 or Type 2 diabetes mellitus or pre-diabetes.
  • Subject has a history of drug and/or alcohol abuse at the time of enrolment.
  • Subject is currently taking medication that can effect glucose metabolism and/or normal gastrointestinal function.
  • Subject is currently participating in another study, or plans to participate in another study during the study period.
  • Women of child-bearing potential who do not use an acceptable method of contraception.
  • Pregnant or nursing (lactating) women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Dietary intervention
Dietary intervention using standardized test meals

Interventional dietary study using standardized test meals and personalized food baskets to investigate the impact of food combination on the glycemic response. The study period is organized as follows:

(Day 1: Continuous blood glucose monitoring system (CGM) activation) Days 2 and 3: Two standardized daily menus (breakfast, lunch, afternoon snack and dinner) provided on a randomized crossover basis.

Days 4 to 7: four standardized test meals, participants will be asked to substitute one meal each day (lunch or dinner) for a test meal according to a pre-defined randomization plan.

Days 8 to 10: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items.

Days 11 to 13: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items and following dietary recommendations developed by the study staff.

(Day 14: CGM sensor removed)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycemic response
Time Frame: 12 days
Measurement of postprandial glucose concentrations
12 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composition of non standardized meals
Time Frame: 10 days
Participants' food diaries
10 days
Adherence to food combination recommendations
Time Frame: 3 days
Based on participants' food diaries while using the food baskets provided on days 11 to 13
3 days
Salivary alpha-amylase activity
Time Frame: Baseline
Amylolytic activity of salivary alpha-amylase
Baseline
AMY 1 copy number
Time Frame: Baseline
Salivary amylase gene (AMY1) copy number
Baseline
Dietary patterns
Time Frame: Baseline
Food Frequency Questionnaire
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 18, 2022

Primary Completion (ACTUAL)

September 5, 2022

Study Completion (ACTUAL)

September 5, 2022

Study Registration Dates

First Submitted

July 7, 2022

First Submitted That Met QC Criteria

July 11, 2022

First Posted (ACTUAL)

July 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 3, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • GlucoMatchMaker

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postprandial Glycemia

Clinical Trials on Test meals and food baskets

3
Subscribe